BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37719893)

  • 1. BAYESIAN INFERENCE AND DYNAMIC PREDICTION FOR MULTIVARIATE LONGITUDINAL AND SURVIVAL DATA.
    Zou H; Zeng D; Xiao L; Luo S
    Ann Appl Stat; 2023 Sep; 17(3):2574-2595. PubMed ID: 37719893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate functional mixed model with MRI data: AnĀ application to Alzheimer's disease.
    Zou H; Xiao L; Zeng D; Luo S;
    Stat Med; 2023 May; 42(10):1492-1511. PubMed ID: 36805635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease.
    Zou H; Li K; Zeng D; Luo S;
    Stat Med; 2021 Dec; 40(30):6855-6872. PubMed ID: 34649301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease.
    Li C; Xiao L; Luo S
    Biometrics; 2022 Jun; 78(2):435-447. PubMed ID: 33501651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease.
    Li K; Luo S
    Stat Methods Med Res; 2019 Feb; 28(2):327-342. PubMed ID: 28750578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Functional Joint Models for Multivariate Longitudinal and Time-to-Event Data.
    Li K; Luo S
    Comput Stat Data Anal; 2019 Jan; 129():14-29. PubMed ID: 30559575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.
    Li K; Luo S
    Stat Med; 2019 Oct; 38(24):4804-4818. PubMed ID: 31386218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ontology-based approach for harmonization and cross-cohort query of Alzheimer's disease data resources.
    Hao X; Li X; Zhang GQ; Tao C; Schulz PE; ; Cui L
    BMC Med Inform Decis Mak; 2023 Aug; 23(Suppl 1):151. PubMed ID: 37542312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional survival forests for multivariate longitudinal outcomes: Dynamic prediction of Alzheimer's disease progression.
    Lin J; Li K; Luo S
    Stat Methods Med Res; 2021 Jan; 30(1):99-111. PubMed ID: 32726189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort-Specific Optimization of Models Predicting Preclinical Alzheimer's Disease, to Enhance Screening Performance in the Middle of Preclinical Alzheimer's Disease Clinical Studies.
    Sato K; Mano T; Ihara R; Suzuki K; Niimi Y; Toda T; Iwatsubo T; Iwata A
    J Prev Alzheimers Dis; 2021; 8(4):503-512. PubMed ID: 34585226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network.
    Liang W; Zhang K; Cao P; Liu X; Yang J; Zaiane O
    Comput Biol Med; 2021 Nov; 138():104935. PubMed ID: 34656869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease.
    Li K; Luo S
    Stat Med; 2017 Sep; 36(22):3560-3572. PubMed ID: 28664662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of neurodegeneration over time between healthy ageing and Alzheimer's disease cohorts via Bayesian inference.
    Cespedes MI; Fripp J; McGree JM; Drovandi CC; Mengersen K; Doecke JD
    BMJ Open; 2017 Feb; 7(2):e012174. PubMed ID: 28174220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A joint model for multivariate longitudinal and survival data to discover the conversion to Alzheimer's disease.
    Kang K; Pan D; Song X
    Stat Med; 2022 Jan; 41(2):356-373. PubMed ID: 34726280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study.
    You J; Zhang YR; Wang HF; Yang M; Feng JF; Yu JT; Cheng W
    EClinicalMedicine; 2022 Nov; 53():101665. PubMed ID: 36187723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian latent time joint mixed effect models for multicohort longitudinal data.
    Li D; Iddi S; Thompson WK; Donohue MC;
    Stat Methods Med Res; 2019 Mar; 28(3):835-845. PubMed ID: 29168432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAD: A deep learning architecture to predict progression of Alzheimer's disease.
    Al Olaimat M; Martinez J; Saeed F; Bozdag S;
    bioRxiv; 2023 Jan; ():. PubMed ID: 36778453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.